Researchers Submit Patent Application, "Compositions and Methods For Treating Migraine", for Approval (USPTO 20240024340).
In: Cannabis & Marijuana News, 2024-02-13, S. N.PAG
serialPeriodical
Zugriff:
A patent application has been submitted for a treatment of migraines using compositions containing cannabidiol (CBD) and/or psilocybin, potentially combined with a mushroom blend. The application outlines methods for reducing migraine symptoms by administering loading doses of psilocybin followed by maintenance doses, which may also include CBD and a mushroom composition. Migraines are a costly neurological disorder often associated with anxiety and depression. The patent application aims to provide improved methods for treating and preventing migraines by administering psilocybin or a derivative, along with a dried mushroom blend or cannabidiol, in various dosage forms. The dried mushroom blend may include mushrooms from various genera. [Extracted from the article]
Copyright of Cannabis & Marijuana News is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Compositions and Methods For Treating Migraine", for Approval (USPTO 20240024340).
|
---|---|
Zeitschrift: | Cannabis & Marijuana News, 2024-02-13, S. N.PAG |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|